Search Results 1421-1430 of 16216 for monoclonal antibody

  1. Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma - Mayo Clinic

    Patients positive for hepatitis C (HCV) antibody are eligible only if polymerase chain reaction is negative for HCV RNA. Negative urine pregnancy test done ...

  2. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Effectiveness of AMG 397 in Subjects With Multiple Myeloma, NHL, and AML - Mayo Clinic

    ... antibody: hepatitis B virus DNA by polymerase chain reaction (PCR) is necessary. Detectable hepatitis B virus DNA suggests occult hepatitis B. Positive ...

  3. A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer - Mayo Clinic

    -Negative hepatitis C virus (HCV) antibody test at screening, or positive HCV antibody test followed by a negative HCV RNA test at screening -Male ...

  4. (Apex) CGT9486 in Patients With Advanced Systemic Mastocytosis - Mayo Clinic

    ... antibody 6. History of clinically significant bleeding event within 30 days before the first dose of study drug or need for therapeutic anticoagulation on ...

  5. Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorder - Mayo Clinic

    Antibodies: ≥ 21 days must have elapsed from infusion of last dose of antibody, and toxicity related to prior antibody therapy must be recovered to grade ≤ 1; ...

  6. Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer - Mayo Clinic

    ... antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways). Prior treatment with ...

  7. Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough (MACS-1) - Mayo Clinic

    ... monoclonal antibody therapy). Participation in another clinical trial that does not allow co-enrollment within 4 weeks prior to the Screening/Baseline Visit ...

  8. Neurology - Clinical trials

    This is the first time this novel technology has been applied to mild TBI and the anticipated results are theoretical. Antineuronal Antibody Positivity ...

  9. Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    Any systemic anti-cancer therapy (e.g., chemotherapy, immunotherapy or biological therapy [including monoclonal antibodies]) within 28 days prior to day of ...

  10. Rheumatology - Clinical trials

    ... antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. Daratumumab to Treat Active Lupus Nephritis. Rochester ...